These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5872967)

  • 1. [Concentration of 17-ketosteroids in the urine of breast cancer patients].
    Smiller RR
    Vopr Onkol; 1965; 11(10):39-43. PubMed ID: 5872967
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary steroid excretion in patients with advanced breast cancer.
    Fotherby K; Sellwood RA; Burn JI
    Br J Surg; 1970 Nov; 57(11):859. PubMed ID: 5482303
    [No Abstract]   [Full Text] [Related]  

  • 3. Observations on urinary 17-ketosteroids in breast cancer patients.
    Singh RK; Udupa KN
    J Postgrad Med; 1977 Oct; 23(4):172-4. PubMed ID: 615263
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urinary excretion of neutral 17-ketosteroids, androsterone and etiocholanolone in healthy women and women with early and advanced breast cancer].
    Bacigalupo G; Lingk H
    Arch Geschwulstforsch; 1968; 32(1):95-107. PubMed ID: 5678251
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary steroid excretion in patients with advanced breast cancer.
    Fotherby K; Sellwood RA; Burn JI
    Br J Surg; 1968 Nov; 55(11):869. PubMed ID: 5687022
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of endocrine ablative surgery on the urinary excretion of 17-ketosteroids in advanced cancer of the breast.
    HOBKIRK R
    J Clin Endocrinol Metab; 1958 Jun; 18(6):636-42. PubMed ID: 13539175
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of urinary 17-ketosteroid fractions in breast cancer--correlation with the effect of adrenalectomy in progressive breast cancer].
    Sakauchi N; Abe O; Kusama M; Takatani O; Kato N
    Saishin Igaku; 1968 Feb; 24(2):463-70. PubMed ID: 4239286
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary steroids and breast disease.
    Gleave EN; Griffiths K; Cameron E; Wilson D; Campbell H; Forrest AP
    Br J Surg; 1969 Aug; 56(8):627. PubMed ID: 5797766
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on circadian periodicity of urinary corticoids in carcinoma of the breast.
    Singh R; Singh RK; Mahdi AA; Misra S; Rai SP; Singh D; Cornélissen G; Halberg F
    In Vivo; 1998; 12(1):69-73. PubMed ID: 9575428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic changes in breast carcinoma. I. Urinary excretions of ketosteroid and catecholamine.
    Maity CR; Burma DP
    Indian J Cancer; 1973 Sep; 10(3):351-5. PubMed ID: 4785883
    [No Abstract]   [Full Text] [Related]  

  • 11. [17-ketosteroid changes in breast cancer during testosterone propionate treatment].
    Mindlin SS; Smiller RR
    Vopr Onkol; 1970; 16(7):17-20. PubMed ID: 5482837
    [No Abstract]   [Full Text] [Related]  

  • 12. [The relationship between the course of mammary gland cancer and age and hormonal features of the body].
    Solovko AIu
    Vopr Onkol; 1969; 15(5):73-7. PubMed ID: 5391126
    [No Abstract]   [Full Text] [Related]  

  • 13. The excretion of 17-ketosteroids in the urine of patients with generalised carcinomatosis secondary to carcinoma of the breast.
    ALLEN BJ; HAYWARD JL; MERIVALE WH
    Lancet; 1957 Mar; 272(6967):496-9. PubMed ID: 13407045
    [No Abstract]   [Full Text] [Related]  

  • 14. [Endocrine characterization of mammary carcinoma].
    Görlich M
    Arch Geschwulstforsch; 1970; 36(4):385-93. PubMed ID: 5513535
    [No Abstract]   [Full Text] [Related]  

  • 15. [Steroid balance in breast cancers of varying histological structure].
    Samundzhan EM; Gorevaia AN; Kartavova NS; Nekrasov PIa
    Vopr Onkol; 1980; 26(9):37-41. PubMed ID: 6252695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Considerations of 1246 determinations of 17-ketosteroids in 1017 patients with mammary and gynecological pathology; malignant or benign tumors].
    PUEBLA JM; YANEZ M
    Sem Med; 1956 Sep; 109(13):540-5. PubMed ID: 13380511
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma dehydroepiandrosterone concentration in normal women and in patients with benign and malignant breast disease.
    Thomas BS; Kirby P; Symes EK; Wang DY
    Eur J Cancer (1965); 1976 May; 12(5):405-9. PubMed ID: 133803
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sex chromatin and hormonal status in patients with breast neoplasms].
    Shevchenko IT; Loboda VI; Blekherman NA; Podobinskiĭ MIa
    Sov Med; 1969 Aug; 32(8):61-4. PubMed ID: 5381927
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between urinary steroids and estrogen receptor content in women with early breast cancer.
    Hajj YJ
    Eur J Cancer (1965); 1977 Jul; 13(7):749-52. PubMed ID: 598398
    [No Abstract]   [Full Text] [Related]  

  • 20. [Content of 17-ketosteroids and pregnandiol in urine in normal women and in breast cancer and other mastopathies].
    ESKIN Ia; KAZHDAN VI; SVIATUKHINA OV
    Probl Endokrinol Gormonoter; 1956; 2(5):57-60. PubMed ID: 13389427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.